Name
RF7-02 (J): Alpelisib plus fulvestrant for PIK3CA-mutated, HR+/HER2- advanced breast cancer post-CDK4/6i (EPIK-B5) - Commentary by: Prof Yutaka Yamamoto
Date & Time
Wednesday, December 3, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL